April 13, 2020 / 6:54 PM / 2 years ago

Fed Circuit orders new trial in Abbott drug test patent case

A U.S. appeals court on Friday granted patent monetization company Rembrandt IP Management a new trial in an infringement case it brought against an Abbott Laboratories diagnostic testing subsidiary.

The U.S. Court of Appeals for the Federal Circuit said a retrial was warranted because a California judge had misinterpreted key terms in a Rembrandt patent on drug testing technology.

To read the full story on Westlaw Practitioner Insights, click here: bit.ly/2y84srp

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below